Ethics

AIDS vaccine fails, long HIV fight still ahead

Published in AIDS Weekly, March 17th, 2003

Though a once-promising AIDS vaccine candidate failed a significant test, scientists and activists still applauded the biotechnology company for conducting an ethical experiment and said the results can be used to further the field.

When VaxGen, Inc. first announced its intention to recruit more than 5,000 volunteers for its vaccine test, many feared the experiment would only arm its participants with a false sense of protection and tempt them to engage in high-risk sex.

But the company and its researchers launched an aggressive educational program for its participants and incidents of risky behavior actually decreased.

"VaxGen's...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (2003-03-17)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry